• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

牛磺罗定对脑肿瘤细胞的作用。

The effect of taurolidine on brain tumor cells.

作者信息

Stendel Ruediger, Stoltenburg-Didinger Gisela, Al Keikh Claudia Lotte, Wattrodt Michaela, Brock Mario

机构信息

Department of Neurosurgery, Benjamin Franklin Medical Center, Free University of Berlin, Germany.

出版信息

Anticancer Res. 2002 Mar-Apr;22(2A):809-14.

PMID:12014655
Abstract

BACKGROUND

Although an inhibiting effect of the antibacterial substance taurolidine on several tumor cell lines was suggested in 1990, no specific research has been performed concerning its effect on brain tumor cells.

MATERIALS AND METHODS

Monolayers of rat-derived C6 glioma, mouse-derived HT22 neuronal tumor, and human-derived U373 astrocytoma/glioblastoma cell lines were cultured and incubated with 1 microg/ml to 4 mg/ml of taurolidine. Neuronal and glial brain cells were obtained from rat fetuses at day 15 of gestation and incubated with taurolidine to investigate its effect on normal brain cells.

RESULTS

Following incubation with taurolidine, the tumor cells started to shrink and to become denser. Ultrastructurally, shrinkage of cytoplasm and condensation and marginalization of chromatin could be observed. Exposure to taurolidine at concentrations of 2.8 microg/ml to 2 mg/ml led to cell death of the evaluated tumor cell types. Results of flow cytometry suggested a fragmentation of DNA. Phosphatidylserine expression increased from 6% to 25% following exposure to taurolidine at a concentration of 25 microg/ml. Normal brain cells did not show any significant changes following incubation with taurolidine.

CONCLUSION

The characteristics identified by light and electron microscopy and the data obtained by flow cytometry indicate an apoptotic mechanism of cell death via currently unknown pathways. Taurolidine was found to have a direct and selective antineoplastic effect on glial and neuronal brain tumor cells in vitro.

摘要

背景

尽管1990年就有人提出抗菌物质牛磺罗定对几种肿瘤细胞系有抑制作用,但尚未针对其对脑肿瘤细胞的作用进行具体研究。

材料与方法

培养大鼠来源的C6胶质瘤、小鼠来源的HT22神经肿瘤以及人来源的U373星形细胞瘤/胶质母细胞瘤细胞系的单层细胞,并与1微克/毫升至4毫克/毫升的牛磺罗定一起孵育。从妊娠第15天的大鼠胎儿中获取神经和胶质脑细胞,并与牛磺罗定一起孵育,以研究其对正常脑细胞的作用。

结果

用牛磺罗定孵育后,肿瘤细胞开始收缩并变得更致密。在超微结构上,可以观察到细胞质收缩以及染色质凝聚和边缘化。暴露于浓度为2.8微克/毫升至2毫克/毫升的牛磺罗定导致所评估的肿瘤细胞类型发生细胞死亡。流式细胞术结果提示DNA片段化。暴露于浓度为25微克/毫升的牛磺罗定后,磷脂酰丝氨酸表达从6%增加到25%。正常脑细胞与牛磺罗定孵育后未显示任何显著变化。

结论

光镜和电镜所确定的特征以及流式细胞术获得的数据表明,细胞死亡是通过目前未知的途径以凋亡机制发生的。发现牛磺罗定在体外对神经胶质和神经源性脑肿瘤细胞具有直接和选择性的抗肿瘤作用。

相似文献

1
The effect of taurolidine on brain tumor cells.牛磺罗定对脑肿瘤细胞的作用。
Anticancer Res. 2002 Mar-Apr;22(2A):809-14.
2
Enhancement of Fas-ligand-mediated programmed cell death by taurolidine.牛磺罗定增强Fas配体介导的程序性细胞死亡
Anticancer Res. 2003 May-Jun;23(3B):2309-14.
3
Taurolidine: cytotoxic and mechanistic evaluation of a novel antineoplastic agent.牛磺罗定:一种新型抗肿瘤药物的细胞毒性及作用机制评估
Cancer Res. 2001 Sep 15;61(18):6816-21.
4
Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.牛磺罗定通过调节Bcl-2家族蛋白在体外和体内诱导小鼠黑色素瘤细胞凋亡。
J Surg Oncol. 2007 Sep 1;96(3):241-8. doi: 10.1002/jso.20827.
5
The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.新型抗肿瘤药物牛磺罗定对人恶性间皮瘤的影响。
Clin Cancer Res. 2004 Nov 15;10(22):7655-61. doi: 10.1158/1078-0432.CCR-0196-03.
6
Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.牛磺罗定通过消除实体瘤的加速发展和增殖以及手术后释放的循环肿瘤细胞形成器官转移灶,从而提高生存率。
J Surg Res. 2001 Dec;101(2):111-9. doi: 10.1006/jsre.2001.6250.
7
Taurolidine-Fibrin-Sealant-Matrix using spray application for local treatment of brain tumors.
Anticancer Res. 2004 Mar-Apr;24(2B):631-8.
8
Treatment of glioblastoma with intravenous taurolidine. First clinical experience.静脉注射牛磺罗定治疗胶质母细胞瘤。首次临床经验。
Anticancer Res. 2004 Mar-Apr;24(2C):1143-7.
9
Induction of reactive oxygen intermediates-dependent programmed cell death in human malignant ex vivo glioma cells and inhibition of the vascular endothelial growth factor production by taurolidine.牛磺罗定诱导人恶性离体胶质瘤细胞中活性氧中间体依赖性程序性细胞死亡并抑制血管内皮生长因子的产生。
J Neurosurg. 2005 Jun;102(6):1055-68. doi: 10.3171/jns.2005.102.6.1055.
10
Influence of intraperitoneal application of taurolidine/heparin on expression of adhesion molecules and colon cancer in rats undergoing laparoscopy.腹腔内应用牛磺罗定/肝素对腹腔镜手术大鼠黏附分子表达及结肠癌的影响
J Surg Res. 2007 Jan;137(1):75-82. doi: 10.1016/j.jss.2006.07.013. Epub 2006 Nov 15.

引用本文的文献

1
Novel protective role of curcumin and taurine combination against experimental hepatocarcinogenesis.姜黄素与牛磺酸联合对实验性肝癌发生的新型保护作用。
Exp Ther Med. 2017 Jan;13(1):29-36. doi: 10.3892/etm.2016.3952. Epub 2016 Dec 2.
2
Taurolidine cooperates with antineoplastic drugs in neuroblastoma cells.牛磺罗定与抗肿瘤药物在神经母细胞瘤细胞中协同作用。
Genes Cancer. 2014 Nov;5(11-12):460-9. doi: 10.18632/genesandcancer.36.
3
Redox-directed cancer therapeutics: Taurolidine and Piperlongumine as broadly effective antineoplastic agents (review).
氧化还原导向的癌症治疗:牛磺罗定和胡椒碱作为广谱有效的抗肿瘤药物(综述)
Int J Oncol. 2014 Oct;45(4):1329-36. doi: 10.3892/ijo.2014.2566. Epub 2014 Jul 28.
4
Gene expression analysis of cell death induction by taurolidine in different malignant cell lines.不同恶性细胞系中 taurolidine 诱导细胞死亡的基因表达分析。
BMC Cancer. 2010 Oct 30;10:595. doi: 10.1186/1471-2407-10-595.
5
Comparative analysis of cell death induction by Taurolidine in different malignant human cancer cell lines.比较 Taurolidine 在不同人恶性癌细胞系中诱导细胞死亡的作用。
J Exp Clin Cancer Res. 2010 Mar 7;29(1):21. doi: 10.1186/1756-9966-29-21.
6
Taurolidine antiadhesive properties on interaction with E. coli; its transformation in biological environment and interaction with bacteria cell wall.牛磺罗定与大肠杆菌相互作用的抗粘连特性;其在生物环境中的转化及其与细菌细胞壁的相互作用。
PLoS One. 2010 Jan 28;5(1):e8927. doi: 10.1371/journal.pone.0008927.
7
Taurolidine reduces the tumor stimulating cytokine interleukin-1beta in patients with resectable gastrointestinal cancer: a multicentre prospective randomized trial.牛磺罗定可降低可切除胃肠道癌患者体内刺激肿瘤的细胞因子白细胞介素-1β:一项多中心前瞻性随机试验。
World J Surg Oncol. 2009 Mar 23;7:32. doi: 10.1186/1477-7819-7-32.
8
Pharmacokinetics of taurolidine following repeated intravenous infusions measured by HPLC-ESI-MS/MS of the derivatives taurultame and taurinamide in glioblastoma patients.通过高效液相色谱-电喷雾串联质谱法(HPLC-ESI-MS/MS)测定胶质母细胞瘤患者重复静脉输注牛磺罗定后其衍生物牛磺他胺和牛磺酰胺的药代动力学。
Clin Pharmacokinet. 2007;46(6):513-24. doi: 10.2165/00003088-200746060-00005.
9
Prevention of disease progression in a patient with a gastric cancer-re-recurrence. Outcome after intravenous treatment with the novel antineoplastic agent taurolidine. Report of a case.胃癌复发患者疾病进展的预防。新型抗肿瘤药物牛磺罗定静脉治疗后的结果。病例报告。
World J Surg Oncol. 2006 Jun 24;4:34. doi: 10.1186/1477-7819-4-34.
10
Effects of increasing doses of a bolus injection and an intravenous long-term therapy of taurolidine on subcutaneous (metastatic) tumor growth in rats.牛磺罗定大剂量推注及静脉长期治疗对大鼠皮下(转移性)肿瘤生长的影响。
Clin Exp Metastasis. 2005;22(1):77-83. doi: 10.1007/s10585-005-4695-4.